Lymphedema of Upper Limb
25
4
8
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.0%
1 terminated out of 25 trials
91.7%
+5.2% vs benchmark
0%
0 trials in Phase 3/4
9%
1 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (25)
The N-LVA Study: RCT Comparing LVA vs. Sham Surgery in Cancer-related Lymphedema
Myofascial Pain Syndrome in Patients With Breast Cancer-related Lymphedema
Screening For BCRL In Targeted Therapy For Breast Cancer
Lymphovenous Anastomosis for Breast Cancer Lymphedema
LymphoPilot Test for Limb Lymphedema
Auto-Adjustable MOBIDERm Autofit Armsleeve in the Management of Upper Limb Lymphedema.
Reduction of Arm Volume and Improvement in Lymphedema Via Surgery
Evaluation of Respiratory Parameters in Patients With Upper Limb Lymphedema
The Robot-LVA Study: Robot-assisted Microsurgical Lymphaticovenous Anastomosis in Breast Cancer-related Lymphedema
The Relationship Between Primary Lymphedema and Joint Hypermobility
Lymphaticovenous Anastomosis as Treatment for Lymphedema
Different Level of ECSWT in Post Mastectomy Lymphedema
Does Inclusion of Diaphragmatic Breathing Exercises in Complete Decongestive Therapy Provide Further Benefits in Patients With Breast Cancer Related Lymphedema
Body Awareness and Functionality in Lymphedema
Lymphatic Response to Resistance Exercise in Breast Cancer Survivors
MRL in the Upper Extremity
Novel MRI Techniques on Evaluation of Lymphedema
Effects of Physiotherapy in the Treatment of Lymphedema After Breast Cancer
Comparative Effects of KT and PG on UE Lymphedema and Functional Disability After Mastectomy
Effect of Different Bandage Interface Pressures on Breast Cancer Related Lymphedema